ATE348837T1 - Neue 14- und 15-gliedrige ringverbindungen - Google Patents

Neue 14- und 15-gliedrige ringverbindungen

Info

Publication number
ATE348837T1
ATE348837T1 AT04732108T AT04732108T ATE348837T1 AT E348837 T1 ATE348837 T1 AT E348837T1 AT 04732108 T AT04732108 T AT 04732108T AT 04732108 T AT04732108 T AT 04732108T AT E348837 T1 ATE348837 T1 AT E348837T1
Authority
AT
Austria
Prior art keywords
new
link ring
ring connections
connections
link
Prior art date
Application number
AT04732108T
Other languages
German (de)
English (en)
Inventor
Sulejman Alihodzic
John Michael Berge
Richard Lewis Jarvest
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0310962A external-priority patent/GB0310962D0/en
Priority claimed from GB0407391A external-priority patent/GB0407391D0/en
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Inst D O O filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE348837T1 publication Critical patent/ATE348837T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT04732108T 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen ATE348837T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0310962A GB0310962D0 (en) 2003-05-13 2003-05-13 Novel compounds
GB0407391A GB0407391D0 (en) 2004-03-31 2004-03-31 Novel compounds

Publications (1)

Publication Number Publication Date
ATE348837T1 true ATE348837T1 (de) 2007-01-15

Family

ID=33454579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04732108T ATE348837T1 (de) 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen

Country Status (15)

Country Link
US (1) US20070293472A1 (enExample)
EP (1) EP1628989B1 (enExample)
JP (1) JP2006528667A (enExample)
AR (1) AR044304A1 (enExample)
AT (1) ATE348837T1 (enExample)
CA (1) CA2525455A1 (enExample)
CL (1) CL2004001012A1 (enExample)
DE (1) DE602004003809T2 (enExample)
DK (1) DK1628989T3 (enExample)
ES (1) ES2278319T3 (enExample)
HR (1) HRP20070094T3 (enExample)
PL (1) PL1628989T3 (enExample)
PT (1) PT1628989E (enExample)
SI (1) SI1628989T1 (enExample)
WO (1) WO2004101587A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
WO2005108412A1 (en) * 2004-05-06 2005-11-17 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ester linked macrolides useful for the treatment of microbial infections
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
WO2007054295A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited New 4*-substituted erythromycin derivative
US7547679B2 (en) 2005-05-10 2009-06-16 Glaxosmithkline Istrazivacki Center Zagreb D.O.O Ether linked macrolides useful for the treatment of microbial infections
EP1945652A1 (en) * 2005-11-09 2008-07-23 Glaxo Group Limited Macrolones
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
CN102245195B (zh) 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
CA2799937A1 (en) * 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
WO2012034058A1 (en) 2010-09-10 2012-03-15 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
CA2868262A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
HK1217665A1 (zh) 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
HK1218864A1 (zh) 2013-03-15 2017-03-17 森普拉制药公司 用於制备大环内酯抗菌剂的收敛方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4686207A (en) * 1985-11-12 1987-08-11 Abbott Laboratories Erythromycin A 11,12-carbonates and method of use
US5288709A (en) * 1989-03-28 1994-02-22 Abbott Laboratories Erythromycin derivatives
AU3710695A (en) * 1995-04-27 1996-11-18 Laboratorios Aranda, S.A. De C.V. Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
IL126624A0 (en) * 1996-05-07 1999-08-17 Abbott Lab 3-descladinose-2, 3-anhydroerythromycin derivatives
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 １１ａ−アザライド化合物及びその製造方法
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
CA2525455A1 (en) 2004-11-25
AR044304A1 (es) 2005-09-07
CL2004001012A1 (es) 2005-03-18
EP1628989B1 (en) 2006-12-20
US20070293472A1 (en) 2007-12-20
PL1628989T3 (pl) 2007-05-31
DE602004003809D1 (de) 2007-02-01
DK1628989T3 (da) 2007-10-08
ES2278319T3 (es) 2007-08-01
DE602004003809T2 (de) 2007-10-11
EP1628989A1 (en) 2006-03-01
JP2006528667A (ja) 2006-12-21
HRP20070094T3 (hr) 2008-05-31
WO2004101587A1 (en) 2004-11-25
PT1628989E (pt) 2007-03-30
SI1628989T1 (sl) 2007-06-30

Similar Documents

Publication Publication Date Title
FI20010157L (fi) Probioottiyhdistelmä
DE10295851T1 (de) Dachfensterbaueinheit und Einzelteile
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DE60328671D1 (de) Neue aminobenzamidderivate
DE50211353D1 (de) Dichtungsanordnung
DE60233444D1 (de) Teileanbringvorrichtung und teileanbringverfahren
ATE348837T1 (de) Neue 14- und 15-gliedrige ringverbindungen
DE60230883D1 (de) Neue formulierungen und ihre verwendung
DE60336306D1 (de) Photoinitiator, neue verbindung und photohärtbare zusammensetzung
DK1239199T3 (da) Ventilindretning
DE60200863D1 (de) Doppeltelezentrisches Objektiv
DE50205152D1 (de) Abgasturbolader
FR2830063B1 (fr) Joint homocinetique
ATE341560T1 (de) Neue 14- und 15-gliedrige ringverbindungen
DE60334907D1 (de) Neue phthalamidderivate
ATE450543T1 (de) Neue 14- und 15-gliedrige ringverbindungen
EP1390074A4 (en) NEW COMPOSITIONS AND USES THEREOF
ATE378347T1 (de) Neue 14- und 15-gliedrige ringverbindungen
DE50213801D1 (de) Gelenk
DE60232344D1 (de) Neue formulierungen und ihre verwendung
DE50309081D1 (de) Neue diketopyrrolopyrrolpigmente
FI20011346L (fi) Tiivistejärjestely
DE60219418T8 (de) Silanylphenole und -naphthole
DE50110146D1 (de) Dichtungsanordnung
DE60233952D1 (de) Neue serinprotease

Legal Events

Date Code Title Description
EEFA Change of the company name
UEP Publication of translation of european patent specification

Ref document number: 1628989

Country of ref document: EP

REN Ceased due to non-payment of the annual fee